tiprankstipranks
Trending News
More News >
ZyVersa Therapeutics files to sell 4.21M shares of common stock for holders
PremiumThe FlyZyVersa Therapeutics files to sell 4.21M shares of common stock for holders
1M ago
ZyVersa Therapeutics reports FY24 EPS ($8.48) vs. ($1089.70) last year
Premium
The Fly
ZyVersa Therapeutics reports FY24 EPS ($8.48) vs. ($1089.70) last year
1M ago
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
Premium
The Fly
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
1M ago
ZyVersa Therapeutics files to sell 1.64M shares of common stock for holders
PremiumThe FlyZyVersa Therapeutics files to sell 1.64M shares of common stock for holders
5M ago
ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100
Premium
The Fly
ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100
6M ago
ZyVersa Therapeutics Reports Q3 Progress and Outlook
Premium
Company Announcements
ZyVersa Therapeutics Reports Q3 Progress and Outlook
6M ago
ZyVersa highlights review article on inflammasome-induced inflammation
PremiumThe FlyZyVersa highlights review article on inflammasome-induced inflammation
6M ago
ZyVersa Therapeutics announces publication of data on obesity, neuroinflammation
Premium
The Fly
ZyVersa Therapeutics announces publication of data on obesity, neuroinflammation
7M ago
ZyVersa Therapeutics CEO highlights obesity development plans for IC 100
Premium
The Fly
ZyVersa Therapeutics CEO highlights obesity development plans for IC 100
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100